Status:
COMPLETED
Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition
Lead Sponsor:
University of Zurich
Conditions:
Primary Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess and compare the repeatability of SD-OCT (Spectralis™ OCT, Version 6.0, Heidelberg Engineering, Germany) RNFL thickness measurements with a new software (glaucoma...
Detailed Description
The purpose of this study is to assess and compare the repeatability of SD-OCT (Spectralis™ OCT, Version 6.0, Heidelberg Engineering, Germany) RNFL thickness measurements with the new software (method...
Eligibility Criteria
Inclusion
- diagnosis of POAG glaucoma
- male and female patients aged 18 years or older, no upper limit
- written informed consent
- visual acuity of more or equal to 0.5 Snellen
- refractive error between + /- 6.00 D spheric and under or equal than 2.00 D cylindrical
Exclusion
- history of surgery other than uncomplicated cataract surgery
- disease affecting cornea, anterior compartment, lens, vitreous body
- history of severe ocular disease, particularly diseases affecting the optic nerve, other than glaucoma
- history of ocular trauma
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02247284
Start Date
March 1 2015
End Date
December 31 2019
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UniversityHospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091